- Home
- TLSI vs DSP Comparison
TLSI vs DSP Comparison
Compare TLSI & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- DSP
- Stock Information
- Founded
- TLSI 2010
- DSP 1999
- Country
- TLSI United States
- DSP United States
- Employees
- TLSI N/A
- DSP N/A
- Industry
- TLSI Medical Specialities
- DSP EDP Services
- Sector
- TLSI Health Care
- DSP Technology
- Exchange
- TLSI Nasdaq
- DSP Nasdaq
- Market Cap
- TLSI 204.0M
- DSP 220.3M
- IPO Year
- TLSI N/A
- DSP 2021
- Fundamental
- Price
- TLSI $5.43
- DSP $13.28
- Analyst Decision
- TLSI Strong Buy
- DSP Strong Buy
- Analyst Count
- TLSI 5
- DSP 8
- Target Price
- TLSI $10.90
- DSP $21.75
- AVG Volume (30 Days)
- TLSI 146.8K
- DSP 245.8K
- Earning Date
- TLSI 08-13-2025
- DSP 08-11-2025
- Dividend Yield
- TLSI N/A
- DSP N/A
- EPS Growth
- TLSI N/A
- DSP N/A
- EPS
- TLSI N/A
- DSP 0.13
- Revenue
- TLSI $32,141,000.00
- DSP $306,484,000.00
- Revenue This Year
- TLSI $55.52
- DSP $18.36
- Revenue Next Year
- TLSI $54.76
- DSP $15.95
- P/E Ratio
- TLSI N/A
- DSP $101.15
- Revenue Growth
- TLSI 46.20
- DSP 30.64
- 52 Week Low
- TLSI $3.50
- DSP $8.70
- 52 Week High
- TLSI $6.04
- DSP $26.33
- Technical
- Relative Strength Index (RSI)
- TLSI 50.01
- DSP 44.73
- Support Level
- TLSI $5.18
- DSP $12.80
- Resistance Level
- TLSI $5.65
- DSP $13.63
- Average True Range (ATR)
- TLSI 0.35
- DSP 0.64
- MACD
- TLSI -0.02
- DSP -0.01
- Stochastic Oscillator
- TLSI 49.23
- DSP 28.75
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.